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Abstract Obesity during pregnancy may be correlated
with an adverse nutritional status affecting pregnancy and
offspring outcomes. We examined the associations of
prepregnancy body mass index and gestational weight gain
with plasma fatty acid concentrations in mid-pregnancy.
This study was embedded in a population-based prospec-
tive cohort study among 5636 women. We obtained
prepregnancy body mass index and maximum weight gain
during pregnancy by questionnaires. We measured con-
centrations of saturated fatty acid (SFA), monounsaturated
fatty acid (MUFA), n-3 polyunsaturated fatty acid (n-3
PUFA) and n-6 polyunsaturated fatty acid (n-6 PUFA) at a
median gestational age of 20.5 (95 % range 17.1–24.9)
weeks. We used multivariate linear regression models. As
compared to normal weight women, obese women had
higher total SFA concentrations [difference: 0.10 standard
deviation (SD) (95 % Confidence Interval (CI) 0, 0.19)]
and lower total n-3 PUFA concentrations [differ-
ence: - 0.11 SD (95 % CI - 0.20, - 0.02)]. As com-
pared to women with sufficient gestational weight gain,
those with excessive gestational weight gain had higher
SFA concentrations [difference: 0.16 SD (95 % CI 0.08,
0.25)], MUFA concentrations [difference: 0.16 SD (95 %
CI 0.08, 0.24)] and n-6 PUFA concentrations [difference:
0.12 SD (95 % CI 0.04, 0.21)]. These results were not
materially affected by adjustment for maternal character-
istics. Our results suggest that obesity and excessive weight
gain during pregnancy are associated with an adverse fatty
acids profile. Further studies are needed to assess causality
and direction of the observed associations.
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Introduction
Overweight and obesity are major public health problems
across all ages and populations in Western countries [1–8].
Previous studies reported a prevalence of up to 30 %
among pregnant women [9, 10]. Obesity during pregnancy
is associated with increased risks of adverse pregnancy
outcomes, including gestational hypertensive disorders,
gestational diabetes, fetal death and large size for gesta-
tional age infants [11–14]. Recent studies suggest that
maternal obesity and excessive weight gain during preg-
nancy are also associated with adverse cardiovascular
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outcomes in the offspring [14, 15]. The mechanisms
underlying these associations may involve fetal cardio-
vascular and metabolic adaptations in response to increased
transport of specific fatty acids to the placenta and fetus
[16]. Increased body mass index is associated with dys-
lipidemia and insulin resistance during pregnancy, which
may lead to increased circulating free fatty acids concen-
trations [17]. Among adolescents and adults, it has been
shown that a higher body mass index is associated with
higher concentrations of saturated fatty acids (SFAs), lower
concentrations of n-3 polyunsaturated fatty acids (PUFAs)
and higher n-6/n-3 PUFA ratio [18, 19]. A previous study
in the United States among 129 pregnant women suggested
that women who were obese before pregnancy had lower
concentrations of docosahexaenoic acid, an n-3 PUFA, and
arachidonic acid, an n-6 PUFA, whereas concentrations of
eicosapentaenoic acid, an n-3 PUFA, did not differ by
prepregnancy body mass index categories [20]. This study
did not have information on other fatty acid concentrations
available.
Therefore, we examined in a population-based
prospective cohort study among 5636 women, the associ-
ations of prepregnancy body mass index and gestational
weight gain with plasma fatty acid concentrations in mid-
pregnancy.
Methods
Study design
This study was embedded in the Generation R Study, a
population-based prospective cohort study from foetal life
to adulthood in Rotterdam, the Netherlands [21, 22]. The
study has been approved by the Medical Ethical Committee
of the Erasmus MC in Rotterdam (MEC 198.782/2001/31).
All mothers gave written consent. Pregnant women with an
expected delivery date from April 2002 to January 2006
were enrolled in the study. In total, 7131 mothers were
enrolled during pregnancy, of whom 6954 had information
on prepregnancy body mass index measurements available
and gave birth to singleton live born children. Mid-preg-
nancy fatty acids concentrations were measured among
5636 women (Flow chart is given Fig. 1).
Prepregnancy body mass index and gestational
weight gain
At enrollment, we measured height (cm) and weight (kg)
without shoes and heavy clothing, and calculated body
mass index (kg/m2). Information about weight just before
pregnancy was obtained by questionnaire. In our popula-
tion for analysis, 52.3 % of all women were enrolled before
a gestational age of 14 weeks. Correlation of prepregnancy
weight, obtained by questionnaire, and weight measured at
enrollment was 0.95 (P value\0.001). Prepregnancy body
mass index was categorized into 4 categories (underweight
[\20.0 kg/m2], normal weight [20.0–24.9 kg/m2], over-
weight [25.0–29.9 kg/m2], and obese [C30.0 kg/m2]).
Information about maximum weight during pregnancy was
available in a subset of 2697 women and was assessed by
questionnaire 2 months after delivery. According to the
Institute of Medicine guidelines, we defined insufficient
and excessive gestational weight gain in relation to
prepregnancy body mass index (for underweight and nor-
mal weight: total weight gain\11.5 and[16.0 kg; for
overweight: total weight gain\7 and[11.5 kg; for obe-
sity: total weight gain\5 and[9.0 kg, respectively) [23].
Fatty acid status
Venous samples were drawn at a median gestational age of
20.5 weeks (95 % range 17.1–24.9). To analyze fatty acids
concentrations, EDTA plasma samples were selected and
transported to the Division of Metabolic Diseases and
Nutritional Medicine, Dr. von Hauner Children’s Hospital,
University of Munich Medical Center. After being thawed,
the analysis of plasma glycerophospholipid fatty acids was
performed by a sensitive and precise high throughput
method. This method is suitable for applications in large
epidemiological studies [24]. Based on findings from pre-
vious studies, we selected fatty acids for our analyses,
which have been associated with the risk of cardiovascular
and metabolic outcomes in adults, and pregnancy outcomes
[25–30]. Selected saturated fatty acids included total SFA
concentrations, myristic acid (C14:0), palmitic acid
(C16:0) and stearic acid (C18:0). Monounsaturated fatty
acids included total MUFA concentrations, palmitoleic
acid (C16:1n7) and oleic acid (C18:1n9). Polyunsaturated
fatty acid included total n-3 PUFA concentrations, a-li-
nolenic acid (ALA, C18:3n3), eicosapentaenoic acid (EPA,
C20:5n3) and docosahexaenoic acid (DHA, C22:6n3), and
total n-6 PUFA concentrations, linoleic acid (LA,
C18:2n6), dihomo-gamma linolenic acid (DGLA,
C20:3n6) and arachidonic acid (AA, C20:4n6). The ratio of
total n-6/n-3 PUFA was calculated [31].
Covariates
We obtained information on maternal prepregnancy body
mass index, age, education level, ethnicity, parity, smok-
ing, alcohol consumption and folic acid supplement by
questionnaires [21]. First trimester maternal nutritional
information was obtained by food frequency questionnaire
[32].
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Statistical analysis
Differences in subject characteristics between body mass
index categories were examined with 1-way ANOVA
tests. We assessed the associations of prepregnancy body
mass index, continuously and in categories, with fatty
acid concentrations using linear regression models. Next,
we assessed the associations of gestational weight gain,
continuously and in categories, with fatty acid concen-
trations during pregnancy using linear regression models.
To enable comparison of effect estimates, we constructed
standard deviation scores (SDS) [(observed value -
mean)/SD] for each fatty acid concentration. All models
were adjusted for maternal age, educational level, eth-
nicity, parity, smoking, alcohol consumption, folic acid
supplement use and total caloric and fat intake during
pregnancy. We have adjusted the regression models for
these maternal lifestyle factors, as they are known to be
related with the main exposures and outcomes. In addi-
tion, we also adjusted the analyses for folic acid supple-
ment use, which is known to increase plasma
concentrations of docosahexaenoic acid and eicosapen-
taenoic acid [33]. We performed sensitivity analyses
without adjusting for total energy and fat intake. In order
to test if the associations of gestational weight gain with
plasma fatty acid concentrations are influenced by
maternal prepregnancy body mass index, we presented
results from the regression models unadjusted and
adjusted for maternal prepregnancy body mass index.
Also, we tested potential interactions between maternal
prepregnancy body mass index categories and gestational
weight gain for the associations with plasma fatty acid
concentrations. Since we did not observe significant
interactions, we did not perform the analyses focused on
gestational weight gain effects in strata of maternal
prepregnancy body mass index categories. Because of the
correlation between the different fatty acids, we did not
apply correction for multiple testing. In order to reduce
potential bias associated with missing data and to main-
tain statistical power, we performed multiple imputations
of missing covariates by generating 5 independent data-
sets using the Markov Chain Monte Carlo method after
which the pooled effect estimates were calculated. All
analyses were performed using Statistical Package of
Social Sciences version 21.0 for Windows (SPSS Inc,
Chicago, IL).
n=7,131 
Participants enrolled during pregnancy and 
information about prepregnancy maternal 
body mass index available 
n=177 
Excluded due to non-singleton live birth  
n=6,954 
Mothers with prepregnancy body mass index 
available and singleton live birth 
n=5,636 
Mothers with available fatty acids 
measurements  
Prepregnancy body mass analysis: n=5,636 
Gestational weight gain analysis: n=2,697 
n=1,318 
Excluded due to missing fatty acids  
Fig. 1 Flow chart of the
participants
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Results
Subject characteristics
Table 1 shows that obese pregnant women tended to be
younger and lower educated, as compared to normal weight
women. Obese women also tended to have a lower total
energy intake and were more likely to have excessive
weight gain during pregnancy, compared to normal weight
women. Correlations between all fatty acid concentrations
are shown in Supplementary Table S1. Observed mid-
pregnancy fatty acid concentrations according to body
mass index are shown in Supplementary Tables S2.
Table S3 shows characteristics of women according to
gestational weight gain categories.
Saturated and monounsaturated fatty acid
concentrations
Table 2 shows that a 1-SD higher body mass index was
associated with 0.07 SD [95 % confidence interval (CI)
0.04, 0.10] higher total SFA concentrations, and specifi-
cally with higher palmitic acid and stearic acid concen-
trations, and with lower myristic acid concentrations (all
P values\0.05). As compared to normal weight women,
overweight and obese women had higher total SFA con-
centrations (all P values\0.05). A 1-SD higher gestational
weight gain was associated with 0.09 SD (95 % CI 0.05,
0.13) higher total SFA concentrations, and specifically with
higher myristic, palmitic and stearic acid concentrations.
Total saturated fatty acid concentrations were not different
Table 1 Characteristics of mothers (N = 5636)
Body mass categories
Total group
(5636)
Underweight
[\20.0 kg/m2]
(n = 881)
Normal weight
[20.0–24.9 kg/m2]
(n = 3162)
Overweight
[25.0–29.9 kg/m2]
(n = 1094)
Obesity
[C30.0 kg/m2]
(n = 499)
P value*
Maternal characteristics
Age (years) 29.8 (5.2) 29.2 (5.3) 30.1 (5.2) 29.8 (5.2) 29.2 (5.0) \0.01
Height (cm) 167.6 (7.3) 168.7 (7.0) 167.9 (7.3) 166.3 (7.5) 165.7 (7.4) \0.01
Weight (kg) 69.2 (13.1) 56.9 (6.7) 65.7 (7.3) 77.5 (8.6) 95.2 (13.8) \0.01
Body mass index (kg/m2) 23.7 (4.4) 18.9 (0.9) 22.2 (1.4) 26.9 (1.4) 33.9 (3.7) \0.01
Education, N higher
education (%)
2340 (42.9) 389 (45.3) 1508 (48.9) 360 (34.5) 83 (17.8) \0.01
Race/ethnicity, European
N (%)
3259 (58.4) 544 (62.2) 1976 (63.0) 529 (49.1) 210 (42.9) \0.01
Parity, N nulliparous (%) 3230 (57.3) 563 (63.9) 1917 (60.7) 534 (48.8) 216 (43.3) \0.01
Total energy intake (kcal) 2013 (587) 2061 (606) 2040 (574) 1953 (588) 1878 (602) \0.01
Carbohydrates,
energy (%)
49.1 (6.6) 49.3 (6.9) 49.3 (6.5) 48.8 (6.6) 48.1 (7.2) 0.06
Proteins, energy (%) 14.9 (2.7) 14.6 (2.8) 14.9 (2.6) 15.0 (2.7) 15.2 (3.1) 0.03
Fat, energy (%) 35.8 (5.7) 35.9 (5.9) 35.6 (5.5) 36.0 (5.6) 36.6 (6.5) 0.07
Folic acid supplement use
(yes), N (%)
3354 (72.0) 535 (74.5) 1990 (66.9) 596 (66.0) 233 (68.6) \0.01
Smoking during
pregnancy (yes), N (%)
1442 (26.7) 249 (29.4) 778 (25.6) 279 (26.9) 136 (28.5) 0.03
Alcohol consumption
during pregnancy (yes),
N (%)
2785 (51.8) 478 (56.4) 1713 (56.5) 427 (41.6) 167 (35.5) \0.01
Gestational weight gain
(kg)
14.9 (5.7) 14.9 (5.0) 15.4 (5.1) 14.3 (6.4) 11.7 (8.1) \0.01
Gestational weight gain categories
Insufficient, N (%) 546 (20.2) 93 (21.2) 355 (21.6) 62 (13.6) 36 (22.8) \0.01
Sufficient, N (%) 922 (34.2) 198 (45.1) 618 (37.6) 76 (16.7) 30 (19.0)
Excessive, N (%) 1229 (45.6) 148 (33.7) 671 (40.8) 318 (69.7) 92 (58.2)
Values represent mean (SD), median (95 % range), or number of subjects (valid %)
* Differences in subject characteristics between groups were evaluated using 1-way ANOVA test
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between women with insufficient weight gain and with
sufficient weight gain.
Table 3 shows that body mass index was not associated
with total MUFA and oleic acid concentrations. However,
a 1-SD higher body mass index was associated with 0.08
SD (95 % CI 0.06, 0.11) higher palmitoleic acid concen-
trations. A 1-SD higher gestational weight gain was asso-
ciated with 0.10 SD (95 % CI 0.06, 0.13) higher total
MUFA concentrations and all specific MUFA concentra-
tions. Compared to women with sufficient weight gain,
those with excessive weight gain had higher total
MUFA, palmitoleic and oleic acid concentrations (all
P values\0.05).
N-3 and n-6 polyunsaturated fatty acid
concentrations
Table 4 shows that higher body mass index was not associ-
ated with total n-3 PUFA and docosahexaenoic acid con-
centrations, but was associated with lower a-linolenic acid
and eicosapentaenoic acid concentrations (all P val-
ues\0.05). As compared to normal weight women, under-
weight women tended to have lower total n-3 PUFA and all
specific n-3 PUFA concentrations (all P values\0.05).
Higher gestational weight gain was not associated with n-3
PUFA and docosahexaenoic acid concentrations, but was
associated with higher a-linolenic acid eicosapentaenoic
acid concentrations. None of the n-3 PUFA concentrations
were different between women with excessive weight gain as
compared to those with sufficient weight gain.
Table 5 shows that 1-SD higher body mass index was
associated with 0.06 SD (95 % CI 0, 0.09) higher total n-6
PUFAs, and specifically with higher dihomo-gamma
linoelinic acid and arachidonic acid, but with lower linoleic
acid concentrations (all P values\0.05). Compared to
normal weight women, obese women had lower linoleic
acid concentrations, but higher dihomo-gamma and
arachidonic acid concentrations (all P values\0.05). A
1-SD higher gestational weight gain was associated with
0.04 SD (95 % CI 0.01, 0.08) higher total n-6 PUFAs and
specifically with higher dihomo-gamma linoelinic acid
concentrations. As compared to women with sufficient
weight gain, those with excessive weight gain had higher
n-6 PUFA concentrations (P values\0.05). Only linoleic
acid concentrations were not different between normal
weight and obese women.
Figure 2 shows that as compared to normal weight
women, those with obesity tended to have a 0.07 SD (95 %
Table 2 Maternal weight during pregnancy with saturated fatty acid concentrations (N = 5636)
Difference in saturated fatty acid (SFA) concentrations (95 % CI)
Total SFAs (SD) Myristic acid (SD) Palmitic acid (SD) Stearic acid (SD)
Body mass indexa
Underweight [\20.0 kg/m2] -0.18 (-0.25, - 0.10)* -0.03 (-0.10, 0.04) -0.17 (-0.25, - 0.10)* -0.16 (-0.24, -0.09)*
Normal weight [20.0–24.9 kg/m2] Reference Reference Reference Reference
Overweight [25.0–29.9 kg/m2] 0.08 (0.01, 0.14)* -0.13 (-0.19, -0.06)* 0.08 (0.01, 0.15)* 0.08 (0.02, 0.15)*
Obesity [C30.0 kg/m2] 0.10 (0.00, 0.19)* -0.27 (-0.37, -0.18)* 0.13 (0.03, 0.22)* 0.07 (-0.03, 0.16)
Body mass index (SD) 0.07 (0.04, 0.10)* -0.08 (-0.11, -0.06)* 0.08 (0.05, 0.11)* 0.06 (0.04. 0.09)*
Gestational weight gainb
Insufficient gestational weight gain -0.06 (-0.16, 0.05) -0.27 (-0.37, -0.17)* -0.04 (-0.14, 0.06) -0.06 (-0.16, 0.05)
Sufficient gestational weight gain Reference Reference Reference Reference
Excessive gestational weight gain 0.16 (0.08, 0.25)* 0.15 (0.07, 0.23)* 0.15 (0.06, 0.23)* 0.17 (0.09, 0.26)*
Gestational weight gain (SD)c 0.09 (0.05, 0.13)* 0.18 (0.14, 0.22)* 0.08 (0.04, 0.11)* 0.10 (0.06, 0.14)*
Gestational weight gain (SD)d 0.10 (0.06, 0.14)* 0.17 (0.13, 0.21)* 0.09 (0.05, 0.12)* 0.11 (0.07, 0.15)*
* P value\0.05
a Values are regression coefficients (95 % CI) that reflect the difference in SD of saturated fatty acid concentrations for underweight, overweight
and obese women as compared to normal weight women, and per SD increase in prepregnancy body mass index. Models are adjusted for age,
educational level, ethnicity, parity, smoking and alcohol consumption, folic acid supplement use and total caloric and fat intake during pregnancy
b Values are regression coefficients (95 % CI) that reflect the difference in SD of saturated fatty acid concentrations for insufficient weight gain
and excessive weight gain women as compared to women with sufficient weight gain, and per SD increase in weight gain. Models are adjusted
for age, educational level, ethnicity, parity, smoking and alcohol consumption, folic acid supplement use and total caloric and fat intake during
pregnancy. Models for weight gain defined according to the IOM criteria are additionally adjusted for prepregnancy body mass index
c Gestational weight gain SD unadjusted for body mass index
d Gestational weight gain SD adjusted for body mass index
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CI - 0.02, 0.15) higher n-6/n-3 PUFA ratio. Also, as
compared to women with sufficient weight gain, those with
excessive weight gain had a 0.06 SD (95 % CI - 0.01,
0.14) higher n-6/n-3 PUFA ratio.
Additional analysis
Similar results were observed when we did not adjust the
gestational weight gain analyses for maternal prepregnancy
body mass index (Results given in Supplementary Tables S4
and S5). We observed similar results for all analyses without
adjustment for total energy and fat intake (Supplementary
Tables S6–S9). The results from the unadjusted models are
given in Supplementary Tables S10–S13. Results were not
materially different between the adjusted and unadjusted
models.
Discussion
In this population-based cohort study, we observed that
higher prepregnancy body mass index was associated with
higher total SFA and total n-6 PUFA concentrations. Also,
we observed that higher gestational weight gain was,
independent of prepregnancy body mass index, associated
with higher total SFA, MUFA and n-6 PUFA concentrations.
Methodological considerations
This study was embedded in a population-based prospec-
tive cohort with a large number of subjects. To the best of
our knowledge, the current study is the largest population-
based study focused on the associations of body mass index
and weight gain during gestation with fatty acid concen-
trations. However, some limitations need to be discussed.
Within this study, we correlated prepregnancy body mass
index and maximum weight gain with mid-pregnancy fatty
acid concentrations. The timing of these measurements
restricts us for drawing conclusions about the direction of
any association. However, fatty acid patterns in plasma
phospholipids show a relatively high degree of tracking
over time [34, 35]. Information on maternal prepregnancy
weight and maximum weight was self-reported. We
observed high correlations between weight in early and late
pregnancy with prepregnancy weight and maximum
weight, respectively, but self-reported weight might be
underestimated. We measured a large number of fatty acid
concentrations in plasma samples only once during
Table 3 Maternal weight during pregnancy with monounsaturated fatty acid concentrations (N = 5636)
Difference in monounsaturated fatty acids (MUFAs) concentrations (95 % CI)
Total MUFAs (SD) Palmitoleic acid (SD) Oleic acid (SD)
Body mass indexa
Underweight [\20.0 kg/m2] -0.05 (-0.12, 0.02) -0.12 (-0.19, -0.05)* -0.03 (-0.10, 0.04)
Normal weight [20.0–24.9 kg/m2] Reference Reference Reference
Overweight [25.0–29.9 kg/m2] -0.02 (-0.08, 0.05) 0.06 (-0.01, 0.13) -0.03 (-0.10, 0.04)
Obesity [C30.0 kg/m2] -0.02 (-0.11, 0.07) 0.22 (0.13, 0.32)* -0.07 (-0.16, 0.02)
Body mass index (SD) 0 (-0.02, 0.03) 0.08 (0.06, 0.11)* -0.01 (-0.04, 0.01)
Gestational weight gainb
Insufficient gestational weight gain -0.04 (-0.14, 0.06) -0.12 (-0.22, -0.01)* -0.04 (-0.14, 0.06)
Sufficient gestational weight gain Reference Reference Reference
Excessive gestational weight gain 0.16 (0.08, 0.24)* 0.18 (0.10, 0.27)* 0.17 (0.08, 0.24)*
Gestational weight gain (SD)c 0.10 (0.06, 0.13)* 0.13 (0.10, 0.17)* 0.10 (0.06, 0.14)*
Gestational weight gain (SD)d 0.10 (0.06, 0.14)* 0.15 (0.11, 0.19)* 0.10 (0.06, 0.14)*
* P value\0.05
a Values are regression coefficients (95 % CI) that reflect the difference in SD of monounsaturated fatty acid concentrations for underweight,
overweight and obese women as compared to normal weight women, and per SD increase in prepregnancy body mass index. Models are adjusted
for age, educational level, ethnicity, parity, smoking and alcohol consumption, folic acid supplement use and total caloric and fat intake during
pregnancy
b Values are regression coefficients (95 % CI) that reflect the difference in SD of monounsaturated fatty acid concentrations for insufficient
weight gain and excessive weight gain women as compared to women with sufficient weight gain, and per SD increase in weight gain. Models
are adjusted for age, educational level, ethnicity, parity, smoking and alcohol consumption, folic acid supplement use and total caloric and fat
intake during pregnancy. Models for weight gain defined according to the IOM criteria are additionally adjusted for prepregnancy body mass
index
c Gestational weight gain SD unadjusted for body mass index
d Gestational weight gain SD adjusted for body mass index
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pregnancy. No information was available about fatty acid
concentrations in other trimesters. Fatty acids measured in
plasma may reflect a time frame of dietary intake of
approximately 2 weeks and seem to be reasonable indica-
tors for the recent intake [36]. Unfortunately, no informa-
tion was available about erythrocyte lipid levels, which
would reflect a longer intake period. We assessed maternal
dietary intake during first trimester by a food frequency
questionnaire (FFQ) and adjusted the main analyses for
maternal total energy and fat intake. No differences in
results were observed with and without adjustment for total
energy and fat intake. Unfortunately, these FFQs were not
validated for assessing maternal dietary fatty acids intake.
Further observational and experimental studies are needed
to explore the associations of maternal dietary fatty acids
intake with maternal body mass index and gestational
weight gain. Although, we were able to adjust our analyses
for various potential confounders, residual confounding
might still be an issue as in any observational study.
Interpretation of main findings
Overweight and obesity during pregnancy are important
public health problems and are associated with adverse
maternal and neonatal outcomes [9, 37]. Multiple previous
studies have reported that higher prepregnancy body mass
index and excessive gestational weight gain are associated
with increased risks of gestational diabetes, neonatal mor-
tality, and obesity in offspring [11, 12, 15, 37–39]. The
mechanism linking higher maternal obesity and excessive
gestational weight gain with offspring outcomes may include
fetal overnutrition [16]. Fetal exposure to increased con-
centrations of free fatty acids may lead to intrauterine
metabolic adaptations and disproportionate fetal growth
[40]. Increased concentrations of free fatty acids during
pregnancy are associated with childhood obesity [41, 42].
Previously, we have shown that higher maternal n-3 PUFA
and lower n-6 PUFA concentrations in pregnancy are also
associated with lower childhood systolic blood pressure [43].
Results from previous studies support associations of
obesity with fatty acid concentrations. A study among 124
adults in Australia showed that obese subjects had lower
plasma n-3 PUFA concentrations [19]. A systematic review
based on 21 studies showed that overweight or obese adults
had lower linoleic acid and higher dihomo-gamma-li-
nolenic acid, n-6 PUFAs [44]. A study among 120 ado-
lescents aged 12 years old from France showed that
overweight adolescents had higher SFA concentrations and
Table 4 Maternal weight during pregnancy with n-3 polyunsaturated fatty acid concentrations (N = 5636)
Difference in n-3 Polyunsaturated fatty acids (PUFAs) concentrations (95 % CI)
Total n-3
PUFAs (SD)
a-Linolenic
acid (SD)
Eicosapentaenoic
acid (SD)
Docosahexaenoic
acid (SD)
Body mass indexa
Underweight [\20.0 kg/m2] -0.11 (-0.18, -0.05)* 0.06 (-0.01, 0.13) -0.03 (-0.10, 0.04) -0.13 (-0.20, -0.06)*
Normal weight [20.0–24.9 kg/m2] Reference Reference Reference Reference
Overweight [25.0–29.9 kg/m2] -0.04 (-0.11, 0.02) -0.17 (-0.24, -0.11)* -0.05 (-0.11, 0.02) -0.01 (-0.07, 0.06)
Obesity [C30.0 kg/m2] -0.11 (-0.20, -0.02)* -0.32 (-0.41, -0.23)* -0.10 (-0.19, -0.01)* -0.05 (-0.14, 0.04)
Body mass index (SD) -0.02 (-0.04, 0.01) -0.12 (-0.15, -0.09)* -0.03 (-0.05, -0.01)* 0.01 (-0.02, 0.03)
Weight gainb
Insufficient gestational weight gain -0.07 (-0.17, 0.03) -0.14 (-0.24, -0.04)* -0.18 (-0.28, -0.07)* -0.01 (-0.11, 0.09)
Sufficient gestational weight gain Reference Reference Reference Reference
Excessive gestational weight gain 0.01 (-0.08, 0.09) 0.05 (-0.03, 0.14) 0.02 (-0.07, 0.11) -0.02 (-0.11, 0.06)
Gestational weight gain (SD)c 0.03 (-0.01, 0.06) 0.09 (0.05, 0.13)* 0.08 (0.04, 0.12)* -0.02 (-0.06, 0.02)
Gestational weight gain (SD)d 0.02 (-0.02, 0.06) 0.07 (0.04, 0.11)* 0.08 (0.04, 0.12)* -0.02 (-0.06, 0.02)
* P value\0.05
a Values are regression coefficients (95 % CI) that reflect the difference in SD of n-3 PUFA concentrations for underweight, overweight and
obese women as compared to normal weight women, and per SD increase in prepregnancy body mass index. Models are adjusted for, age,
educational level, ethnicity, parity, smoking and alcohol consumption, folic acid supplement use and total caloric and fat intake during pregnancy
b Values are regression coefficients (95 % CI) that reflect the difference in SD of n-3 PUFA concentrations for insufficient weight gain and
excessive weight gain women as compared to women with sufficient weight gain, and per SD increase in weight gain. Models are adjusted for,
age, educational level, ethnicity, parity, smoking and alcohol consumption, folic acid supplement use and total caloric and fat intake during
pregnancy. Models for weight gain defined according to the IOM criteria are additionally adjusted for prepregnancy body mass index
c Gestational weight gain SD unadjusted for body mass index
d Gestational weight gain SD adjusted for body mass index
Body mass index, gestational weight gain and fatty acid concentrations during pregnancy: the… 1181
123
lower total n-3 PUFA concentrations [45]. Only one study
has assessed the associations of body mass index with fatty
acid concentrations among pregnant women [20]. This
study among 129 pregnant women in the US showed that
as compared with lean women, obese women had lower
docosahexaenoic acid, an n-3 PUFA, and arachidonic, an
n-6 PUFA, concentrations during pregnancy [20]. No
information about other fatty acid concentrations was
available. In line with these previous results, we observed
that higher body mass index was associated with higher
total n-6 PUFA concentrations. Obese women had lower
linoleic acid concentrations, but higher dihomo-gamma and
arachidonic acid concentrations. All n-3 PUFA concen-
trations tended to be lower among obese women with the
strongest association for a-linolenic acid. For the SFAs,
obese women had lower myristic acid concentrations and
higher palmitic acid concentrations, whereas for the
MUFAs, obese women had higher palmitoleic acid con-
centrations. These results suggest that the associations of
body mass index with fatty acid concentrations in pregnant
women are in line with those observed in non-pregnant
adults.
We also assessed the associations of gestational weight
gain with fatty acid concentrations. Gestational weight gain
is a complex measure, which reflects maternal fat accu-
mulation, fluid and blood volume expansion, and fetal and
placental growth [23]. Excessive gestational weight gain is
defined as increased weight gain between the time of
conception and the onset of labor and is a related with
pregnancy and offspring outcomes [14]. We observed that
total SFA concentrations, specifically myristic, palmitic
and stearic acids, were higher among women with exces-
sive gestational weight gain. Excessive gestational weight
gain was also associated with total MUFA concentrations,
specifically palmitoleic and oleic acids. We observed that
excessive gestational weight gain was associated with
higher concentrations of total n-6 PUFA, specifically
dihomo-gamma linoleic and arachidonic acids, but no
association was observed with n-3 PUFA concentrations.
The observed associations of excessive gestational weight
gain with fatty acid concentrations were present with and
without adjustment of body mass index. Thus, women with
excessive gestational weight gain during pregnancy have,
independent of their prepregnancy body mass index, an
adverse fatty acid profile.
Our results suggest that pregnant women with either a
high body mass index or high gestational weight gain have
an adverse fatty acids profile, characterized by higher
Table 5 Maternal weight during pregnancy with n-6 polyunsaturated fatty acid concentrations (N = 5636)
Difference in n-6 Polyunsaturated fatty acids (PUFAs) concentrations (95 % CI)
Total n-6 PUFAs (SD) Linoleic acid (SD) Dihomo-gamma
linolenic acid (SD)
Arachidonic acid (SD)
Body mass indexa
Underweight [\20.0 kg/m2] -0.17 (-0.24, -0.09)* -0.03 (-0.11, 0.04) -0.27 (-0.34, -0.20)* -0.23 (-0.30, -0.16)*
Normal weight [20.0–24.9 kg/m2] Reference Reference Reference Reference
Overweight [25.0–29.9 kg/m2] 0.09 (0.02, 0.16)* -0.03 (-0.09, 0.04) 0.16 (0.10, 0.23)* 0.23 (0.16, 0.30)*
Obesity [C30.0 kg/m2] 0.06 (-0.04, 0.15) -0.23 (-0.32, -0.13)* 0.35 (0.26, 0.45)* 0.45 (0.35, 0.54)*
Body mass index (SD) 0.06 (0, 0.09)* -0.05 (-0.08, -0.02)* 0.16 (0.14, 0.19)* 0.19 (0.17, 0.22)*
Weight gainb
Insufficient gestational weight gain 0.02 (-0.08, 0.12) 0.02 (-0.09, 0.12) -0.08 (-0.18, 0.02) 0.07 (-0.04, 0.17)
Sufficient gestational weight gain Reference Reference Reference Reference
Excessive gestational weight gain 0.12 (0.04, 0.21)* 0.05 (-0.04, 0.13) 0.29 (0.21, 0.37)* 0.05 (-0.03, 0.13)
Gestational weight gain (SD)c 0.04 (0.01, 0.08)* 0.02 (-0.02, 0.06) 0.15 (0.11, 0.19)* -0.03 (-0.06, 0.01)
Gestational weight gain (SD)d 0.05 (0.02, 0.09)* 0.01 (-0.02, 0.05) 0.18 (0.14, 0.22)* -0.00 (-0.04, 0.04)
* P value\0.05
a Values are regression coefficients (95 % CI) that reflect the difference in SD of n-6 PUFA concentrations for underweight, overweight and
obese women as compared to normal weight women, and per SD increase in prepregnancy body mass index. Models are adjusted for age,
educational level, ethnicity, parity, smoking and alcohol consumption, folic acid supplement use and total caloric and fat intake during pregnancy
b Values are regression coefficients (95 % CI) that reflect the difference in SD of n-6 PUFA concentrations for insufficient weight gain and
excessive weight gain women as compared to women with sufficient weight gain, and per SD increase in weight gain. Models are adjusted for
age, educational level, ethnicity, parity, smoking and alcohol consumption, folic acid supplement use and total caloric and fat intake during
pregnancy. Models for weight gain defined according to the IOM criteria are additionally adjusted for prepregnancy body mass index
c Gestational weight gain SD unadjusted for body mass index
d Gestational weight gain SD adjusted for body mass index
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concentrations of SFA, MUFA and n-6 PUFA, and lower
concentrations of n-3 PUFA. From our study, it is difficult
to determine whether body mass index and gestational
weight gain cause adverse fatty acid profiles, or whether
the direction of the association is reversed. It has been
suggested that higher n-6 PUFA concentrations lead to
higher adipose tissue development through promotion of
preadipocyte differentiation and that higher n-3 PUFA
concentrations decreases adipose tissue mass and sup-
presses development of obesity [46, 47]. Also, saturated
fatty acids and the monounsaturated fatty acids stimulate
adipocyte differentiation and triacylglycerol accumulation
[48]. In the other direction, obesity alters adipose tissue
metabolic and endocrine function and leads to an increased
release of fatty acids, affecting subsequent adiposity and
thus creating a vicious cycle [49]. Further studies are
needed to explore the causality and direction of the
observed associations. Studies with longitudinal measure-
ments of both weight and fatty acid concentrations before
and during pregnancy may help to identify the direction of
these associations. Also, experimental and Mendelian
Randomization studies may help to assess the causality of
the observed associations [50, 51].
Conclusion
We observed that higher prepregnancy body mass index
was associated with higher total SFA and total n-6 PUFA
concentrations, whereas higher gestational weight gain was
associated with higher total SFA, MUFA and n-6 PUFA
concentrations. Further observational and experimental
studies are needed for replication and to explore the
direction and underlying mechanism of these associations.
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Fig. 2 Maternal body mass index (a) and gestational weight gain
(b) with n-6/n-3 PUFA ratio (N = 5636). a Values are regression
coefficients (95 % CI) that reflect the difference in SD of n-6/n-3
PUFAs ratio for underweight, overweight and obese women as
compared to normal weight women, and per SD increase in
prepregnancy body mass index. PUFAs Polyunsaturated fatty acids.
Models are adjusted for maternal age, educational level, ethnicity,
parity, smoking and alcohol consumption, folic acid supplement use
and total caloric and fat intake during pregnancy. *P value\0.05.
b Values are regression coefficients (95 % CI) that reflect the
difference in SD of n-6/n-3 PUFAs ratio for insufficient weight gain,
and excessive weight gain women as compared to women with
sufficient weight gain, and per SD increase in weight gain. Models are
adjusted for age, educational level, ethnicity, parity, smoking and
alcohol consumption, folic acid supplement use and total caloric and
fat intake during pregnancy. Models for weight gain are additionally
adjusted for prepregnancy body mass index. *P value\0.05
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